563 Results

People

  1. Zelenetz
    Zelenetz
  2. Moskowitz
    Moskowitz
  3. Yahalom
    Yahalom
  4. Noy
    Noy
  5. De Angelis
    De Angelis
  6. Perales
    Perales
  7. Abrey
    Abrey
  8. Palomba
    Palomba
  9. Younes
    Younes
  10. Matasar
    Matasar

Groups

  1. Department of Medicine (377)
  2. Hematologic Malignancies, Division of (338)
  3. Center for Hematologic Malignancies (292)
  4. Lymphoma (192)
  5. Survivorship Research (98)
  6. Tow Center for Developmental Oncology (TCDO) (72)
  7. Bone Marrow Transplant (65)
  8. GSK Faculty (60)
  9. Epidemiology and Biostatistics (58)
  10. Adult Leukemia (53)
  1. "rituximab"
Formats
  1. Journal Article (489)
  2. Review (36)
  3. Research Letter (13)
  4. Editorial (9)
  5. Correspondence (6)
  6. Meeting Abstract (4)
  7. Book Section (2)
  8. Conference Paper (2)
  9. Guidelines (2)
Groups
  1. Department of Medicine (377)
  2. Hematologic Malignancies, Division of (338)
  3. Center for Hematologic Malignancies (292)
  4. Lymphoma (192)
  5. Survivorship Research (98)
  6. Tow Center for Developmental Oncology (TCDO) (72)

More Groups

People
  1. Andrew Zelenetz (87)
  2. Craig Moskowitz (52)
  3. Joachim Yahalom (39)
  4. Ariela Noy (35)
  5. Lisa De Angelis (32)
  6. Paul Hamlin (32)

More People

Years
  1. 2025 (21)
  2. 2024 (36)
  3. 2023 (36)
  4. 2022 (28)
  5. 2021 (14)
  6. 2020 (25)

More Years

Publications
  1. Blood (43)
  2. Leukemia and Lymphoma (38)
  3. Journal of Clinical Oncology (32)
  4. Haematologica (21)
  5. British Journal of Haematology (20)
  6. Journal of the National Comprehensive Cancer Network (16)

More Publications

Publishers
  1. Elsevier Inc. (70)
  2. American Society of Hematology (61)
  3. Taylor & Francis Group (44)
  4. Springer (42)
  5. American Society of Clinical Oncology (36)
  6. Nature Publishing Group (28)

More Publishers

Results (563)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Improved efficacy of tafasitamab plus lenalidomide versus systemic therapies for relapsed/refractory DLBCL: RE-MIND2, an observational retrospective matched cohort study
    Journal Article

    Nowakowski, G. S.; Yoon, D. H.; Peters, A.; Mondello, P.; Joffe, E.; Fleury, I.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • ASTCT Committee on Practice Guidelines survey on Evaluation & management of diffuse large B-cell lymphoma after failure of chimeric antigen receptor T cell therapy (CAR-T) therapy
    Journal Article

    Ahmed, N.; Kumar, A.; Kharfan-Dabaja, M. A.; DeFilipp, Z.; Herrera, A.; Hashmi, S.; Dholaria, B.; Perales, M. A.; Carpenter, P. A.; Hamadani, M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Granulocyte transfusions in patients with chronic granulomatous disease undergoing hematopoietic cell transplantation or gene therapy
    Journal Article

    Arnold, D. E.; Chellapandian, D.; Parikh, S.; Mallhi, K.; Marsh, R. A.; Heimall, J. R.; Grossman, D.; Chitty-Lopez, M.; Murguia-Favela, L.; Gennery, A. R.; more...
    Journal of Clinical Immunology (2022)

    Fulltext@MSK | Save
  • Land(mark) ahoy: PFS24 in relapsed/refractory diffuse large B-cell lymphoma
    Editorial

    Matasar, M.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
    Research Letter

    Jaeger, U.; Tam, C. S.; Borchmann, P.; McGuirk, J. P.; Johansen, M.; Waller, E. K.; Jaglowski, S.; Andreadis, C.; Foley, S. R.; Westin, J. R.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Rituximab, methotrexate, carmustine, etoposide, and prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: A retrospective single-center study
    Journal Article

    Reiss, S. N.; Yerram, P.; Modelevsky, L.; Grommes, C.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma
    Journal Article

    Fischer, T.; Ni, A.; Bantilan, K. S.; Soumerai, J. D.; Alperovich, A.; Batlevi, C.; Younes, A.; Zelenetz, A. D.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Obinutuzumab in the treatment of B-cell malignancies: A comprehensive review
    Review

    Davies, A.; Kater, A. P.; Sharman, J. P.; Stilgenbauer, S.; Vitolo, U.; Klein, C.; Parreira, J.; Salles, G.
    Future Oncology (2022)

    Fulltext@MSK | Save
  • A retrospective cohort study of treatment outcomes of adult patients with relapsed or refractory follicular lymphoma (ReCORD-FL)
    Journal Article

    Salles, G.; Schuster, S. J.; Fischer, L.; Kuruvilla, J.; Patten, P. E. M.; von Tresckow, B.; Smith, S.; Ubieto, A. J.; Davis, K. L.; Nagar, S.; more...
    HemaSphere (2022)

    Fulltext@MSK | Save
  • The potential of pirtobrutinib in multiple B-cell malignancies
    Review

    Jensen, J. L.; Mato, A. R.; Pena, C.; Roeker, L. E.; Coombs, C. C.
    Therapeutic Advances in Hematology (2022)

    Fulltext@MSK | Save